GlassScriptPhysician profile
Nicholas Craig Smith
NPI 1811127673
$10,508.71
in general payments reported to CMS, 2019-2025
35 companies · $782 in 2025
The $782 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,789 · 2020: $549 · 2021: $411 · 2022: $1,561 · 2023: $2,661 · 2024: $755 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,137 · Travel and Lodging: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,137.17 |
| Travel and Lodging | $1,060.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $2,568.10 | 2019-2020 | |
| Paragon 28, INC. | $1,878.07 | 2019-2023 | Monkey Rings |
| Cgg Medical INC | $1,015.33 | 2023-2025 | |
| Organogenesis INC. | $880.07 | 2020-2025 | Puraply Antimicrobial, Puraply Wound Matrix, Nushield |
| Stryker Corporation | $820.12 | 2020-2025 | Salvation, Inbone, N/A |
| Arthrex, INC. | $621.16 | 2023 | |
| Horizon Therapeutics Plc | $514.34 | 2019-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $501.68 | 2023-2025 | |
| Smith+Nephew, INC. | $332.69 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Abbott Laboratories | $234.31 | 2023-2024 | Proclaim, Eterna |
| Amgen INC. | $177.56 | 2024-2025 | Krystexxa |
| Averitas Pharma INC. | $117.14 | 2023 | Qutenza |
| Zyla Life Sciences, INC. | $78.85 | 2019 | |
| Pfizer INC. | $73.57 | 2019-2020 | |
| Solventum Corporation | $67.97 | 2024-2025 | V.A.C.Ulta, Activ.A.C., Prevena |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $65.15 | 2022-2024 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $60.90 | 2024-2025 | |
| Kerecis Limited | $56.56 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polarityte, INC. | $54.77 | 2019 | |
| Grt US Holding, INC. | $45.11 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $44.28 | 2023 | Seglentis |
| Medtronic, INC. | $43.52 | 2023-2024 | Venaseal |
| Convatec INC. | $24.45 | 2023 | |
| Ani Pharmaceuticals, INC. | $24.43 | 2025 | Purified Cortrophin Gel |
| Melinta Therapeutics, LLC | $22.67 | 2023 | Kimyrsa |
| Next Science LLC | $22.42 | 2022 | |
| Biowound Solutions, INC. | $22.38 | 2025 | Bio-Connekt |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.62 | 2020 | |
| Nevro Corp. | $20.27 | 2024 | Senza |
| Dynasplint Systems INC. | $19.21 | 2025 | Dynasplint |
| Cardiovascular Systems INC. | $18.93 | 2023 | |
| Integra Lifesciences Corporation | $18.26 | 2020 | |
| Bioventus LLC | $17.40 | 2024 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $15.39 | 2021 | |
| Orthofix Medical, INC. | $10.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.